FDA Inspection
GlaxoSmithKline BiologicalsGlaxoSmithKline Biologicals – FDA Inspection, Nov 8, 2022
Record Details
This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on November 8, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- GlaxoSmithKline Biologicals
- Inspection Date
- November 8, 2022
- Product Type
- Biologics
View Company Profile
ID · e865d539-7363-43f7-b06a-9bb6bef4b8da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1193493
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of GlaxoSmithKline Biologicals
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for GlaxoSmithKline Biologicals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.